查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1383699

獸醫生物標記市場 - 全球產業規模、佔有率、趨勢、機會和預測，2018-2028 年按動物類型、產品類型、按應用、疾病類型、地區、競爭預測和機會細分，2018-2028F

Veterinary Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Animal Type, By Product Type, By Application, By Disease Type, By Region, By Competition Forecast & Opportunities, 2018-2028F
出版日期: | 出版商: TechSci Research | 英文 190 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2022 年全球獸醫生物標記市場價值為 7.6012 億美元，預計在預測期內將出現令人印象深刻的成長，到 2028 年CAGR為12.33%。全球獸醫生物標記市場是指獸醫醫療保健產業中涉及以下領域的領域：使用生物標記診斷疾病、監測動物健康和評估動物治療效果。生物標記是可測量的指標，例如蛋白質、基因或代謝物，可用於檢測和量化動物的各種生理和病理過程。

主要市場促進因素

動物疾病盛行率增加

市場概況
預測期 2024-2028
2022 年市場規模 76012萬美元
2028 年市場規模 150877萬美元
2023-2028 年CAGR 12.33%
成長最快的細分市場 伴侶動物
最大的市場 北美洲

近年來，全球獸醫生物標記市場出現了顯著成長，部分原因是一個令人擔憂的趨勢：動物疾病的盛行率不斷上升。隨著我們對動物健康的了解加深以及人類與其動物夥伴之間的聯繫日益緊密，對診斷、治療和預防動物疾病的創新解決方案的需求激增。動物王國，無論是伴侶動物或牲畜，都面臨著各種疾病日益嚴重的威脅。動物的傳染病、癌症、代謝紊亂和與年齡相關的疾病呈上升趨勢。疾病發生率的激增給獸醫、寵物主人和牲畜生產者帶來了嚴峻的挑戰。有效管理動物疾病的關鍵往往在於早期發現和及時介入。獸醫生物標記是可測量的生物指標，提供了有效的解決方案。這些生物標記可以在血液、尿液、組織或其他體液中進行識別，可以提供有關動物健康狀況的重要資訊，幫助獸醫在疾病的早期診斷。獸醫生物標記徹底改變了動物疾病診斷。它們使獸醫能夠超越傳統的臨床觀察並提供更準確和客觀的評估。這反過來又可以帶來更明智的治療決策，從而顯著改善患病動物的預後。正如在人類醫療保健領域一樣，個人化醫療在獸醫護理領域也越來越受到關注。生物標記物使獸醫能夠根據個別動物的獨特需求量身定做治療計劃。這種個人化提高了治療的有效性，同時最大限度地減少了副作用，從而帶來更好的患者治療效果。生物標記在疾病監測和流行病學研究中也發揮著至關重要的作用。透過追蹤動物族群內生物標記的變化，研究人員可以監測疾病的傳播，識別潛在的疫情爆發，並更有效地實施預防措施。在畜牧業中，生物標記對於維持牛群和羊群的健康至關重要。及時發現疾病可以防止整個人口受到影響，從而最大限度地減少農民的經濟損失。生物標記是確保糧食安全和永續畜牧生產不可或缺的工具。疾病從動物傳染給人類，即人畜共通傳染病，近年來引起了廣泛關注。隨著此類疾病盛行率的上升，有效監控和控制的需求也隨之增加。獸醫生物標記對於研究人畜共通傳染病和預防其傳播具有無價的價值。

目錄

第 1 章：產品概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 研究年份
    • 主要市場區隔

第 2 章：研究方法

  • 研究目的
  • 基線方法
  • 主要產業夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量與驗證
  • 假設和限制

第 3 章：執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第 4 章：客戶之聲

第 5 章：全球獸醫生物標記市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依動物類型（伴侶動物（狗、貓等）、生產動物（牛、豬等））
    • 依產品類型（生物標記、試劑盒和試劑、生物標記讀取器）
    • 按應用（疾病診斷、臨床前研究、其他）
    • 依疾病類型（發炎和傳染病、心血管疾病、骨骼肌疾病、腫瘤、其他）
    • 按地區
    • 按公司分類 (2022)
  • 產品市場地圖
    • 依動物類型
    • 依產品類型
    • 按應用
    • 依疾病類型
    • 按地區

第 6 章：北美獸醫生物標記市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依動物類型（伴侶動物（狗、貓等）、生產動物（牛、豬等））
    • 依產品類型（生物標記、試劑盒和試劑、生物標記讀取器）
    • 按應用（疾病診斷、臨床前研究、其他）
    • 依疾病類型（發炎和傳染病、心血管疾病、骨骼肌疾病、腫瘤、其他）
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第 7 章：歐洲獸醫生物標記市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依動物類型（伴侶動物（狗、貓等）、生產動物（牛、豬等））
    • 依產品類型（生物標記、試劑盒和試劑、生物標記讀取器）
    • 按應用（疾病診斷、臨床前研究、其他）
    • 依疾病類型（發炎和傳染病、心血管疾病、骨骼肌疾病、腫瘤、其他）
    • 按國家/地區
  • 歐洲：國家分析
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙

第 8 章：亞太地區獸醫生物標記市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依動物類型（伴侶動物（狗、貓等）、生產動物（牛、豬等））
    • 依產品類型（生物標記、試劑盒和試劑、生物標記讀取器）
    • 按應用（疾病診斷、臨床前研究、其他）
    • 依疾病類型（發炎和傳染病、心血管疾病、骨骼肌疾病、腫瘤、其他）
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國

第 9 章：南美洲獸醫生物標記市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依動物類型（伴侶動物（狗、貓等）、生產動物（牛、豬等））
    • 依產品類型（生物標記、試劑盒和試劑、生物標記讀取器）
    • 按應用（疾病診斷、臨床前研究、其他）
    • 依疾病類型（發炎和傳染病、心血管疾病、骨骼肌疾病、腫瘤、其他）
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲獸醫生物標記市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依動物類型（伴侶動物（狗、貓等）、生產動物（牛、豬等））
    • 依產品類型（生物標記、試劑盒和試劑、生物標記讀取器）
    • 按應用（疾病診斷、臨床前研究、其他）
    • 依疾病類型（發炎和傳染病、心血管疾病、骨骼肌疾病、腫瘤、其他）
    • 按國家/地區
  • MEA：國家分析
    • 南非獸醫生物標記
    • 沙烏地阿拉伯獸醫生物標記
    • 阿拉伯聯合大公國獸醫生物標記
    • 科威特獸醫生物標記

第 11 章：市場動態

  • 促進要素
  • 挑戰

第 12 章：市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第 13 章：波特的五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第14章：競爭格局

  • 商業概覽
  • 產品供應
  • 最近的發展
  • 財務（據報導）
  • 主要人員
  • SWOT分析
    • Zoetis Inc.
    • Virbac SA
    • Life Diagnostics Inc
    • Acuvet Biotech
    • Merck & Co., Inc.
    • IDEXX Laboratories, Inc.
    • Mercodia AB
    • Antech Diagnostics Inc

第 15 章：策略建議

第 16 章：關於我們與免責聲明

簡介目錄
Product Code: 17609

Global Veterinary Biomarkers Market has valued at USD 760.12 million in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 12.33% through 2028. The Global Veterinary Biomarkers Market refers to the sector within the veterinary healthcare industry that deals with the use of biomarkers for diagnosing diseases, monitoring animal health, and assessing treatment efficacy in animals. Biomarkers are measurable indicators, such as proteins, genes, or metabolites, that can be used to detect and quantify various physiological and pathological processes in animals.

Key Market Drivers

Increasing Prevalence of Animal Diseases

Market Overview
Forecast Period2024-2028
Market Size 2022USD 760.12 Million
Market Size 2028USD 1508.77 Million
CAGR 2023-202812.33%
Fastest Growing SegmentCompanion Animals
Largest MarketNorth America

The Global Veterinary Biomarkers Market has witnessed significant growth in recent years, owing in part to a concerning trend: the increasing prevalence of animal diseases. As our understanding of animal health deepens and the bond between humans and their animal companions grows stronger, the demand for innovative solutions to diagnose, treat, and prevent diseases in animals has surged. The animal kingdom, whether it includes companion animals or livestock, is facing a mounting threat from various diseases. Infectious diseases, cancers, metabolic disorders, and age-related illnesses are on the rise among animals. This surge in disease incidence presents a critical challenge to veterinarians, pet owners, and livestock producers alike. The key to effective disease management in animals often lies in early detection and timely intervention. Veterinary biomarkers, which are measurable biological indicators, offer a potent solution. These biomarkers can be identified in blood, urine, tissues, or other bodily fluids and can provide crucial information about an animal's health status, helping veterinarians diagnose diseases in their early stages. Veterinary biomarkers have revolutionized disease diagnosis in animals. They enable veterinarians to go beyond traditional clinical observations and provide more accurate and objective assessments. This, in turn, leads to better-informed treatment decisions, which can significantly improve the prognosis for sick animals. Just as in human healthcare, personalized medicine is gaining traction in veterinary care. Biomarkers allow veterinarians to tailor treatment plans to individual animals' unique needs. This personalization enhances the effectiveness of therapies while minimizing adverse effects, leading to better patient outcomes. Biomarkers also play a vital role in disease surveillance and epidemiological studies. By tracking changes in biomarker profiles within animal populations, researchers can monitor the spread of diseases, identify potential outbreaks, and implement preventive measures more efficiently. In the livestock industry, biomarkers are essential for maintaining herd and flock health. Timely detection of diseases can prevent entire populations from being affected, minimizing economic losses for farmers. Biomarkers are indispensable tools for ensuring food security and sustainable livestock production. The spillover of diseases from animals to humans, known as zoonotic diseases, has gained significant attention in recent years. As the prevalence of such diseases rises, so does the need for effective monitoring and control. Veterinary biomarkers are invaluable for studying zoonotic diseases and preventing their transmission.

Personalized Veterinary Care

The Global Veterinary Biomarkers Market is experiencing remarkable growth, driven by a powerful trend that mirrors advance in human medicine: personalized veterinary care. As the bond between humans and their animal companions deepens, there is an increasing demand for tailored healthcare solutions that take into account the unique needs of individual animals. This demand is propelling the growth of the veterinary biomarkers market. Veterinary medicine has come a long way from a one-size-fits-all approach. Today, veterinarians and pet owners alike recognize that each animal is unique, with distinct genetic makeup, environmental factors, and health histories. Personalized veterinary care acknowledges these differences and seeks to provide tailored treatment plans for each patient. At the heart of personalized veterinary care are biomarkers-measurable indicators found in bodily fluids, tissues, or other biological materials. These biomarkers provide valuable insights into an animal's health, from identifying genetic predispositions to tracking disease progression. Veterinary biomarkers help veterinarians make more informed decisions about diagnostics, treatment strategies, and preventive measures. One of the key benefits of personalized veterinary care is early disease detection. Biomarkers allow veterinarians to identify disease markers long before clinical symptoms manifest. This early detection provides a crucial window of opportunity for timely intervention and treatment, potentially improving patient outcomes and reducing the cost of healthcare. Biomarkers also enable veterinarians to create personalized treatment plans. By analyzing an animal's unique biomarker profile, veterinarians can choose the most suitable medications, therapies, and dietary recommendations. This tailored approach optimizes treatment effectiveness while minimizing potential side effects. For animals with chronic conditions such as diabetes, arthritis, or kidney disease, biomarkers allow for ongoing monitoring. Veterinarians can track biomarker levels to assess the progression of the disease and adjust treatment plans accordingly. This proactive approach enhances the animal's quality of life. Genetic biomarkers are instrumental in assessing an animal's predisposition to certain diseases. Genetic testing can reveal susceptibility to conditions like cancer or hereditary disorders. Armed with this information, veterinarians can implement preventive measures and early screening.

Companion Animal Ownership Trends

Companion animals, including dogs, cats, birds, and small mammals, have long held a special place in our hearts and homes. Recent years have witnessed a remarkable surge in companion animal ownership trends worldwide. This growing bond between humans and their pets has not only enriched our lives but is also driving the growth of the Global Veterinary Biomarkers Market. Companion animals are no longer just pets; they are integral members of families. The modern trend toward pet humanization has elevated the status of pets from mere animals to cherished companions. This shift has significantly increased the emphasis on pet health and well-being. With the increasing humanization of pets, pet owners are more aware than ever of the health needs of their animal companions. They are willing to invest in preventive healthcare, regular check-ups, and advanced diagnostics to ensure their pets lead healthy and happy lives. Veterinary biomarkers have emerged as indispensable tools in the early detection of diseases in companion animals. These measurable indicators found in blood, urine, or tissues can identify potential health issues before they manifest clinical symptoms. Early detection can be a game-changer in treating diseases effectively and improving the overall prognosis. Just like humans, companion animals experience age-related health concerns. Conditions such as arthritis, diabetes, and heart disease become more prevalent in older pets. Biomarkers play a vital role in monitoring these conditions, allowing for timely interventions and personalized treatment plans. The trend of personalized medicine is not limited to human healthcare. In veterinary medicine, biomarkers enable veterinarians to tailor healthcare plans to the specific needs of individual pets. This personalized approach optimizes treatment outcomes while minimizing adverse effects. Cancer is a significant concern in companion animals, and early detection is key to successful treatment. Biomarkers are instrumental in identifying cancer markers, allowing for prompt diagnosis and the development of targeted treatment strategies. Genetic biomarkers are critical for assessing an animal's predisposition to certain hereditary diseases. Genetic testing can provide valuable insights into potential health risks, allowing pet owners to take preventive actions or early screening measures.

Livestock Farming Efficiency

The Global Veterinary Biomarkers Market is experiencing remarkable growth, driven by a powerful force that impacts food security and agricultural sustainability: livestock farming efficiency. As the global population continues to grow, the demand for animal-based products like meat, dairy, and eggs is rising exponentially. To meet this demand, farmers and ranchers are embracing innovations that improve livestock health and productivity. This, in turn, is fueling the growth of the veterinary biomarkers market. With the global population projected to reach 9 billion by 2050, the agriculture industry faces the daunting task of producing more food while minimizing the environmental impact. Livestock farming plays a critical role in this challenge, as it provides a significant source of protein for human consumption. Efficient livestock farming relies on healthy animals that grow and reproduce effectively. Biomarkers are at the forefront of efforts to optimize livestock health. These measurable indicators in blood, urine, or tissues help farmers and veterinarians monitor the well-being of animals, detect diseases early, and ensure timely interventions. Disease outbreaks can have devastating consequences for livestock farms, leading to economic losses and food shortages. Biomarkers enable the early detection of diseases, facilitating prompt treatment and the isolation of affected animals, thereby preventing the spread of infections. Reproductive efficiency is critical in livestock farming. Biomarkers can help identify animals that are in optimal breeding condition, increasing the chances of successful pregnancies and reducing the time and resources required for reproduction. Biomarkers also play a role in assessing the nutritional status of livestock. By tracking biomarker levels, farmers can adjust feed and nutrition plans to ensure that animals receive the right nutrients for healthy growth. The livestock industry has been under scrutiny for the overuse of antibiotics, leading to concerns about antibiotic resistance. Biomarkers can aid in identifying the specific pathogens causing illnesses, enabling targeted treatments and reducing the need for broad-spectrum antibiotics. Healthy livestock produces higher-quality meat, milk, and eggs. Biomarker-based monitoring and interventions can result in improved product quality, which benefits both producers and consumers.

Key Market Challenges

Validation and Standardization

Validating and standardizing biomarker assays for veterinary use is essential for ensuring accuracy and reliability. Establishing consistent standards and methodologies is challenging due to the diversity of animal species, breeds, and health conditions. This lack of standardization can hinder the widespread adoption of biomarker-based diagnostics and treatments.

Cost Constraints

Cost is a significant barrier to the adoption of biomarker-based diagnostics and treatments, particularly in resource-limited settings. Developing biomarker assays and acquiring the necessary equipment can be expensive. Reducing costs while maintaining quality is an ongoing challenge for market players.

Education and Awareness

Many veterinarians and pet owners may not be fully aware of the benefits of biomarker-based diagnostics and personalized veterinary care. Education and awareness campaigns are essential to inform stakeholders about the advantages of biomarkers in early disease detection, treatment optimization, and preventive care.

Data Privacy and Security

Biomarker-based diagnostics generate a wealth of sensitive data, including genetic information. Ensuring the privacy and security of this data is crucial to gaining the trust of pet owners and maintaining ethical standards. Compliance with data protection regulations poses an additional challenge for market players.

Key Market Trends

Rise of Point-of-Care Diagnostics

Point-of-care diagnostics are revolutionizing veterinary medicine by providing rapid and on-site testing capabilities. These portable and user-friendly devices allow veterinarians to perform biomarker-based tests right in the clinic, enabling quicker diagnoses and immediate treatment decisions. The convenience of point-of-care testing is expected to drive its adoption in veterinary practices.

Advancements in Genomic Biomarkers

Genomic biomarkers, which involve the study of an animal's genetic material, are gaining prominence in veterinary medicine. These biomarkers provide insights into an animal's predisposition to diseases, helping veterinarians tailor preventive measures and early screening based on genetic risk factors.

Microbiome and Metabolomics Biomarkers

Research into the microbiome and metabolomics is expanding our understanding of how gut health and metabolism influence overall animal well-being. Biomarkers associated with the microbiome and metabolomics are expected to play a more significant role in disease diagnosis and dietary recommendations for animals.

Immunotherapy and Targeted Treatments

Immunotherapy and targeted treatments are emerging as powerful tools in veterinary medicine. Biomarkers play a crucial role in identifying suitable candidates for these therapies and monitoring treatment responses. Expect to see more biomarker-driven personalized treatment plans for animals with cancer and immune-related disorders.

Segmental Insights

Animal Type Insights

Based on the category of Animal Type, companion animals segment held the largest share in 2022. This dominance can be attributed to the increasing adoption rates of dogs and the notable prevalence of diseases among them. Data from the American Kennel Club (AKC) revealed a rise in U.S. households owning dogs, increasing from 50% in 2018 to 54% in 2021. Furthermore, according to the 2022 FEDIAF European Pet Food Industry report, 46% of households in Europe, totaling 90 million, owned pets, and the dog population in the region was estimated to be 92.9 million in 2021. Additionally, the COVID-19 pandemic prompted many individuals worldwide to adopt dogs for emotional support.

In 2022, the production animal segment also experienced substantial growth and held a significant share based on animal type. This growth is attributed to the expanding population of production animals like cattle and other livestock, particularly in developing countries such as China, India, and Japan. For instance, data from the national dairy development board indicated that the cattle population in India increased from 185 million in 2003 to 193 million in 2019. Similarly, the total bovine population grew from 283 million in 2003 to 302 million in 2019. Additionally, the rising prevalence of severe infectious diseases like tuberculosis among production animals has raised concerns, driving the adoption of various diagnostic methods.

Product Type Insights

In 2022, the product category of biomarkers, kits, and reagents dominated the market share, primarily due to the extensive availability of well-known biomarker brands and test kits introduced by leading industry players. Veterinarians show a preference for biomarker test kits because they offer precise and sensitive disease diagnostic methods. These kits play a crucial role in comprehending the progression of illnesses and delivering accurate treatments that target the specific biological indicators of the disease. Furthermore, there has been a growing awareness of the applications of biomarkers in the veterinary field, particularly in developing nations, which has contributed to the market's recent growth.

Looking ahead, biomarker readers are expected to maintain a significant market share in the foreseeable future, driven by the increasing rate of diagnosis in veterinary practices. Unlike human biomarker readers, which lack accuracy and calibration for animal readings, key industry players have introduced dedicated veterinary biomarker readers. For instance, Virbac launched an intuitive and compact laser-based fluorescent reader known as the 'speed reader,' designed to precisely measure biomarker concentrations in animal serum or plasma samples. This development is a key driver behind the segment's growth within the market.

Regional Insights

In 2022, North America emerged as the dominant region in the veterinary biomarkers market, boasting the highest market share. This significant share can be attributed to several factors, including the substantial presence of key industry players, the implementation of various strategic initiatives by these companies to expand their market reach, an upsurge in research activities, an increase in diagnostic rates, and a rising population of animals, accompanied by increased veterinary care spending. The proliferation of veterinary clinics staffed with licensed and well-trained veterinarians in these countries is also contributing to the market's growth. For instance, as of 2020, the United States alone had approximately 118,624 licensed veterinarians, predominantly focused on companion animal patients, according to data from the AVMA.

In the European region, which holds the second-largest market share, the presence of major key players like Virbac and ACUVET BIOTECH in European countries is a significant driving force.

Meanwhile, the Asia Pacific region is expected to witness rapid growth, with a projected CAGR in the coming years. This growth can be attributed to increased expenditure on animal healthcare and rising disposable income in key markets, coupled with a growing awareness of the significance of biomarkers in veterinary practices. The escalating demand for timely and accurate disease diagnosis, as well as the trend of pet humanization observed in developing countries like India, are additional factors propelling market expansion in this region.

Key Market Players

Zoetis Inc.

Virbac SA

Life Diagnostics Inc

Acuvet Biotech

Merck & Co., Inc.

IDEXX Laboratories, Inc.

Mercodia AB

Antech Diagnostics Inc

Report Scope:

In this report, the Global Veterinary Biomarkers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Biomarkers Market, By Animal Type:

  • Companion Animals
  • Dogs
  • Cats
  • Others
  • Production Animals
  • Cows
  • Pigs
  • Others

Veterinary Biomarkers Market, By Product Type:

  • Biomarkers
  • Kits & Reagents
  • Biomarker Readers

Veterinary Biomarkers Market, By Application:

  • Disease Diagnostics
  • Preclinical Research
  • Others

Veterinary Biomarkers Market, By Disease Type:

  • Inflammatory & Infectious Diseases
  • Cardiovascular Diseases
  • Skeletal Muscle Diseases
  • Tumor
  • Others

Veterinary Biomarkers Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Biomarkers Market.

Available Customizations:

  • Global Veterinary Biomarkers market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Veterinary Biomarkers Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Animal Type (Companion Animals (Dogs, Cats, Others), Production Animals (Cows, Pigs, Others))
    • 5.2.2. By Product Type (Biomarkers, Kits & Reagents, Biomarker Readers)
    • 5.2.3. By Application (Disease Diagnostics, Preclinical Research, Others)
    • 5.2.4. By Disease Type (Inflammatory & Infectious Diseases, Cardiovascular Diseases, Skeletal Muscle Diseases, Tumor, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2022)
  • 5.3. Product Market Map
    • 5.3.1. By Animal Type
    • 5.3.2. By Product Type
    • 5.3.3. By Application
    • 5.3.4. By Disease Type
    • 5.3.5. By Region

6. North America Veterinary Biomarkers Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Animal Type (Companion Animals (Dogs, Cats, Others), Production Animals (Cows, Pigs, Others))
    • 6.2.2. By Product Type (Biomarkers, Kits & Reagents, Biomarker Readers)
    • 6.2.3. By Application (Disease Diagnostics, Preclinical Research, Others)
    • 6.2.4. By Disease Type (Inflammatory & Infectious Diseases, Cardiovascular Diseases, Skeletal Muscle Diseases, Tumor, Others)
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Veterinary Biomarkers Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Animal Type
        • 6.3.1.2.2. By Product Type
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By Disease Type
    • 6.3.2. Canada Veterinary Biomarkers Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Animal Type
        • 6.3.2.2.2. By Product Type
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By Disease Type
    • 6.3.3. Mexico Veterinary Biomarkers Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Animal Type
        • 6.3.3.2.2. By Product Type
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By Disease Type

7. Europe Veterinary Biomarkers Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Animal Type (Companion Animals (Dogs, Cats, Others), Production Animals (Cows, Pigs, Others))
    • 7.2.2. By Product Type (Biomarkers, Kits & Reagents, Biomarker Readers)
    • 7.2.3. By Application (Disease Diagnostics, Preclinical Research, Others)
    • 7.2.4. By Disease Type (Inflammatory & Infectious Diseases, Cardiovascular Diseases, Skeletal Muscle Diseases, Tumor, Others)
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Veterinary Biomarkers Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Animal Type
        • 7.3.1.2.2. By Product Type
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By Disease Type
    • 7.3.2. United Kingdom Veterinary Biomarkers Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Animal Type
        • 7.3.2.2.2. By Product Type
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By Disease Type
    • 7.3.3. France Veterinary Biomarkers Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Animal Type
        • 7.3.3.2.2. By Product Type
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By Disease Type
    • 7.3.4. Italy Veterinary Biomarkers Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Animal Type
        • 7.3.4.2.2. By Product Type
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By Disease Type
    • 7.3.5. Spain Veterinary Biomarkers Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Animal Type
        • 7.3.5.2.2. By Product Type
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By Disease Type

8. Asia-Pacific Veterinary Biomarkers Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Animal Type (Companion Animals (Dogs, Cats, Others), Production Animals (Cows, Pigs, Others))
    • 8.2.2. By Product Type (Biomarkers, Kits & Reagents, Biomarker Readers)
    • 8.2.3. By Application (Disease Diagnostics, Preclinical Research, Others)
    • 8.2.4. By Disease Type (Inflammatory & Infectious Diseases, Cardiovascular Diseases, Skeletal Muscle Diseases, Tumor, Others)
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Veterinary Biomarkers Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Animal Type
        • 8.3.1.2.2. By Product Type
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By Disease Type
    • 8.3.2. Japan Veterinary Biomarkers Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Animal Type
        • 8.3.2.2.2. By Product Type
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By Disease Type
    • 8.3.3. India Veterinary Biomarkers Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Animal Type
        • 8.3.3.2.2. By Product Type
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By Disease Type
    • 8.3.4. Australia Veterinary Biomarkers Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Animal Type
        • 8.3.4.2.2. By Product Type
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By Disease Type
    • 8.3.5. South Korea Veterinary Biomarkers Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Animal Type
        • 8.3.5.2.2. By Product Type
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By Disease Type

9. South America Veterinary Biomarkers Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Animal Type (Companion Animals (Dogs, Cats, Others), Production Animals (Cows, Pigs, Others))
    • 9.2.2. By Product Type (Biomarkers, Kits & Reagents, Biomarker Readers)
    • 9.2.3. By Application (Disease Diagnostics, Preclinical Research, Others)
    • 9.2.4. By Disease Type (Inflammatory & Infectious Diseases, Cardiovascular Diseases, Skeletal Muscle Diseases, Tumor, Others)
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Veterinary Biomarkers Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Animal Type
        • 9.3.1.2.2. By Product Type
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By Disease Type
    • 9.3.2. Argentina Veterinary Biomarkers Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Animal Type
        • 9.3.2.2.2. By Product Type
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By Disease Type
    • 9.3.3. Colombia Veterinary Biomarkers Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Animal Type
        • 9.3.3.2.2. By Product Type
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By Disease Type

10. Middle East and Africa Veterinary Biomarkers Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Animal Type (Companion Animals (Dogs, Cats, Others), Production Animals (Cows, Pigs, Others))
    • 10.2.2. By Product Type (Biomarkers, Kits & Reagents, Biomarker Readers)
    • 10.2.3. By Application (Disease Diagnostics, Preclinical Research, Others)
    • 10.2.4. By Disease Type (Inflammatory & Infectious Diseases, Cardiovascular Diseases, Skeletal Muscle Diseases, Tumor, Others)
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Veterinary Biomarkers Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Animal Type
        • 10.3.1.2.2. By Product Type
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By Disease Type
    • 10.3.2. Saudi Arabia Veterinary Biomarkers Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Animal Type
        • 10.3.2.2.2. By Product Type
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By Disease Type
    • 10.3.3. UAE Veterinary Biomarkers Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Animal Type
        • 10.3.3.2.2. By Product Type
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By Disease Type
    • 10.3.4. Kuwait Veterinary Biomarkers Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Animal Type
        • 10.3.4.2.2. By Product Type
        • 10.3.4.2.3. By Application
        • 10.3.4.2.4. By Disease Type

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Business Overview
  • 14.2. Product Offerings
  • 14.3. Recent Developments
  • 14.4. Financials (As Reported)
  • 14.5. Key Personnel
  • 14.6. SWOT Analysis
    • 14.6.1. Zoetis Inc.
    • 14.6.2. Virbac SA
    • 14.6.3. Life Diagnostics Inc
    • 14.6.4. Acuvet Biotech
    • 14.6.5. Merck & Co., Inc.
    • 14.6.6. IDEXX Laboratories, Inc.
    • 14.6.7. Mercodia AB
    • 14.6.8. Antech Diagnostics Inc

15. Strategic Recommendations

16. About Us & Disclaimer